Norges Bank’s Lifecore Biomedical LFCR Stock Holding History

Norges Bank’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,400	Closed	-$121K	–	2236
2021 Q1	$121K	Sell	11,400 -93,644	-89%	-$1.05M	﹤0.01%	2125
2020 Q4	$1.14M	Hold	105,044	–	–	﹤0.01%	2018
2020 Q3	$1.02M	Buy	+105,044	New	+$1M	﹤0.01%	2031
2015 Q1	–	Sell	-5,892	Closed	-$81K	–	2304
2014 Q4	$81K	Hold	5,892	–	–	﹤0.01%	2324
2014 Q3	$72K	Sell	5,892 -5,892	-50%	-$73.6K	﹤0.01%	2310
2014 Q2	$148K	Buy	+11,784	New	+$139K	﹤0.01%	2232

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Norges Bank's LFCR Position: Q2 2021 in Review

Norges Bank sold out of Lifecore Biomedical (LFCR) in Q2 2021, closing a stake of 11,400 shares — an estimated $121K sold.

Norges Bank first reported a position in LFCR in Q2 2014 and held it in 6 quarters. The position peaked at $1.14M in Q4 2020. 95 funds tracked by Wall St. Rank hold LFCR as of Q2 2021.

Norges Bank reported no remaining Lifecore Biomedical position as of Q2 2021 after selling out during the quarter.
Norges Bank sold 11,400 Lifecore Biomedical shares in Q2 2021, an estimated $121K.
Norges Bank first reported a position in Lifecore Biomedical in Q2 2014 and held it in 6 quarters.
Norges Bank's Lifecore Biomedical position peaked at $1.14M in Q4 2020.
95 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2021.

Based on Norges Bank's 13F filing for Q2 2021, filed 10 Aug 2021.